MiyakisSLockshinMDAtsumiT, et al.International consensus statement on classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost2006; 4: 295–306.
2.
CerveraRKhamashtaMAFontJ, et al.Clinical and immunologic features of antiphospholipid syndrome in systemic lupus erythematosus. Medicine (Baltimore)1993; 72: 113–124.
3.
TsokosGC. Systemic lupus erythematosus. N Engl J Med2011; 365: 2110–2121.
4.
TektonidouMGAndreoliLLimperM, et al.EULAR Recommendations for management of thrombotic and obstetric antiphospholipid syndrome. Ann Rheum Dis2019; 78: 1296–1304.
5.
Stafford-BradyFJUrowitzMBGladmanDD, et al.Ocular manifestations of systemic lupus erythematosus. Arthritis Rheum1988; 31: 1105–1113.
6.
AshersonRACerveraR. Antiphospholipid antibodies and the eye: a review. Lupus1997; 6: 485–490.
7.
KuriakoseRKBraithwaiteTElksnisM, et al.Retinal vascular occlusions and hemorrhages as presenting signs of antiphospholipid syndrome. Eye (Lond)2012; 26: 785–791.
8.
OhnoSCharDHKimuraAE, et al.Vitreous hemorrhage as an initial manifestation of lupus-related retinal vasculitis: a case report. Clin Ophthalmol2016; 10: 1239–1243.
9.
ZhangYLiHHuangY, et al.Central retinal vein occlusion secondary to systemic lupus erythematosus with antiphospholipid syndrome. Lupus2018; 27: 1539–1542.
10.
WeeningJJD’AgatiVDSchwartzMM, et al.Classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int2004; 65: 521–530.
11.
ContrerasGPardoVLeclercqB, et al.Outcomes in diffuse proliferative lupus nephritis treated with the NIH regimen. Kidney Int2004; 65: 1400–1409.
KavithaMSinghSJosephG, et al.Barriers to diagnosis and care for women with autoimmune reproductive loss in resource-limited settings. Int J Gynecol Obstet2021; 153: 45–52.
